IAG Capital Partners

Based in the Boston biotech and medtech hub, Elucid Bioimaging is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, vascuCAP, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from a single CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services.

Ayar Labs, Inc. develops advanced optical interconnect solutions, specializing in high-density electronic-photonic chiplets and lasers. Its flagship product, TeraPHY, is a monolithic in-package optical I/O solution designed for applications demanding high bandwidth, low latency, and energy efficiency in short-reach interconnects. Complementing TeraPHY, the company offers SuperNova, a multiwavelength light source that provides continuous wave light essential for TeraPHY's operation. By utilizing patented technologies based on industry-standard silicon processing techniques, Ayar Labs aims to enhance interconnect bandwidth density while reducing power consumption, thereby transforming traditional electrical interconnects in the semiconductor and computing sectors. The company's innovations are applicable across various industries, including artificial intelligence, cloud computing, telecommunications, aerospace, and military applications. Founded in 2015 and headquartered in Emeryville, California, Ayar Labs is committed to addressing the challenges posed by increasing data volumes through the miniaturization of fiber optic transceivers.

Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.​

CaliberMind is a B2B Customer Data Platform that powers Revenue Marketers at mParticle, Fidelis Cybersecurity, Datavail and other mid-market enterprises, with the data, business intelligence, and automation they need to grow revenue faster, together with sales. The platform lets marketing and ops teams answer simple business questions and automate manual workflows with 1-click: Which marketing programs generate the most revenue? How is my marketing campaign performing? How fast are we driving revenue through the pipeline? How's our close rate trending over time? Unlike CRM reporting and expensive, general BI tools that take months to implement, run on bad/ partial data and require data analytics skills, CaliberMind can be implemented in one hour by marketing and ops managers. The platform has 10x faster time-to-insights at 10% of the cost of traditional IT/ BI solutions.

Nanoligent is a biotech company, spin-off of the Universitat Autònoma de Barcelona (UAB) and Institut de Recerca de l'Hospital de la Santa Creu I Sant Pau. We are dedicated to drug design and development of targeted-therapeutic biologics .Nanoligent mision is to improve the life of patients by designing new medicines that selectively target the cells affected by disease. With this approach we develope treatments that are more effective and have fewer adverse effects than classical drugs.

Tethr provides an AI-driven communications intelligence platform that analyzes customer conversations to deliver actionable insights. By processing data from various customer interactions, including phone calls and chats, Tethr helps organizations understand the true Voice of the Customer. This platform is built on extensive customer experience research and enables businesses to gather and share valuable insights across their teams. The insights generated can enhance sales performance, boost customer loyalty, and improve compliance, ultimately leading to more informed business decisions and reduced operating costs.

GeneCentric Diagnostics is engaged in the development and commercialization of molecular diagnostic tests aimed at assisting oncologists and patients in cancer treatment. The company has established two primary platform technologies: The Lung Subtype Platform (LSP), which classifies lung cancer patients into specific subtypes to guide therapeutic choices, and the Hypoxia Signature, designed to identify patients likely to benefit from anti-angiogenesis therapies. The LSP has been licensed to Laboratory Corporation of America Holdings and is available as HistoPlusSM: Lung Cancer through its Integrated Oncology division. GeneCentric's innovative partnership model facilitates the translation of significant cancer research into diagnostics that are clinically adopted by pathologists and clinicians. Incorporated in 2011 and located in Durham, North Carolina, GeneCentric aims to enhance treatment outcomes by enabling more precise targeting of therapeutic compounds based on tumor biology.

New View Surgical, Inc. is a Boston-based medical device company that specializes in the development and commercialization of the VisionPort technology, a novel surgical imaging and access system designed for minimally invasive surgery. Founded in 2009, the company has created a proprietary system that integrates four essential devices—a laparoscope, camera, light source, and access port—into a single, easy-to-use, and disposable unit. This innovation aims to provide surgeons with enhanced control over visualization and instrumentation during procedures, addressing various unmet needs within the surgical market. The leadership team comprises experienced professionals in medical device innovation and commercialization, dedicated to delivering impactful solutions that offer both clinical and economic benefits to operating rooms worldwide.

UpGuard's proprietary technology tests an organization's IT infrastructure both internally and externally and calculates the potential risk for future intrusions and outages. Upon evaluating the ongoing configuration state of every server and network device, companies are given an easy-to-understand score called CSTAR — a single number which indicates to IT staff as well as their executives their risk level for data breaches. An organization's CSTAR score can even be used by corporate insurers in creating a cybersecurity insurance policy. Thousands of companies, including ADP, E*TRADE, and Cisco Systems, use UpGuard to validate infrastructure, continuously detect risks, and procure cybersecurity insurance. UpGuard is headquartered in Mountain View, California with offices in Portland, Oregon.

Based in the Boston biotech and medtech hub, Elucid Bioimaging is focused on improving the accuracy, experience, & cost-effectiveness of cardiovascular diagnostic imaging by leveraging machine learning. Elucid's main product, vascuCAP, is the first-ever, FDA-cleared, histologically-validated software for evaluating plaque vulnerability from a single CTA to inform risk of event (heart attack or stroke) & treatment selection. Additionally, Elucid works with pharmaceutical companies, providers, and research organizations to provide quantitative image analysis services.

VenoStent, Inc. is a biomaterials and bioengineering company based in Nashville, Tennessee, with an additional office in Houston, Texas. Established in 2017, the company specializes in developing bioresorbable smart polymers aimed at enhancing vascular surgery outcomes. Its primary product, SelfWrap, is a perivascular wrap designed to minimize complications at the junctions of veins and arteries, particularly for dialysis patients. SelfWrap functions as an external stent that promotes outward vein growth and provides mechanical support, thereby reducing the risk of vein collapse. By focusing on innovative solutions in vascular care, VenoStent aims to improve patient outcomes and transform surgical practices.

OpenDrives LLC specializes in developing network-attached storage solutions tailored for the broadcast, video editing, visual effects, imaging, and digital content creation sectors. The company offers a range of products, including Avalanche, an all-flash storage system designed for high-bandwidth and high-resolution workflows; Spectre, a hybrid storage system that combines SSD and HDD technologies to accommodate dynamic production environments; and Ridgeview, a dense storage solution suitable for nearline and active archive applications. Additionally, OpenDrives provides OPUS, an enterprise-grade management platform specifically crafted for the media and entertainment industries. Established in 2015 and headquartered in Culver City, California, OpenDrives focuses on delivering ultra-high-performance data storage hardware and software to support clients with demanding requirements, such as thousands of concurrent users accessing large video and imaging files in real-time.

Coagulo Medical Technologies, Inc. is a Massachusetts-based company focused on developing advanced testing systems for coagulation management. The company provides a portable and connected precision-medicine platform that enables healthcare professionals to detect, identify, and quantify the effects of various anticoagulants in whole blood. By utilizing a combination of patent-pending coagulation assays, microfluidic technology, and data analytics, Coagulo's system offers actionable results, facilitating personalized diagnosis and management of coagulation-related conditions. This innovative approach aims to improve healthcare outcomes by making coagulation testing more accessible and efficient for both providers and patients.

CoreCare, Inc. operates an artificial intelligence-driven software as a service (SaaS) platform designed for the senior living industry. The platform integrates provider and payer information systems, standardizing scattered data to identify and eliminate inconsistencies. CoreCare's CoreAccess software simplifies the billing process and alleviates financial complexities for healthcare providers. It aggregates and standardizes data from Managed Care Organizations (MCOs) into a single portal, facilitating easier preparation, submission, reconciliation, and reconsideration of reimbursements. By enhancing claim acceptance and improving cash flow, CoreCare enables healthcare businesses to reduce administrative expenses and strengthen their financial position. Founded in 2019 and based in Fort Worth, Texas, CoreCare aims to streamline operations within the healthcare sector.

Obsidio, Inc. develops shear-thinning hydrogel biomaterial technology and manufactures therapeutic devices and universal gel embolization material using that technology. The company’s embolic material, injectable through catheters in a minimally invasive way, helps to stop undesired blood flow through vessels anywhere in the body. Its technology can be used in the treatment of hemorrhage, aneurysm, and cancer. The company was founded in 2018 and is based in Solana Beach, California.

Zopa Limited operates an online marketplace lending platform in the United Kingdom, facilitating peer-to-peer lending by connecting individual borrowers with lenders, including both individuals and institutions. Founded in 2004 and based in London, Zopa offers a variety of loan products, such as car loans, debt consolidation loans, home improvement loans, and wedding loans. The platform categorizes borrowers based on credit ratings and allows lenders to make offers tailored to these grades. Zopa manages the loan process by handling legal paperwork, conducting identity and credit checks, and ensuring repayment through direct debit agreements. The company generates revenue by charging borrowers a fixed fee and lenders a 1% annual fee. Zopa has received multiple awards for its innovation and customer service and is recognized as one of the founding members of the UK's Peer-to-Peer Finance Association.

Tethr provides an AI-driven communications intelligence platform that analyzes customer conversations to deliver actionable insights. By processing data from various customer interactions, including phone calls and chats, Tethr helps organizations understand the true Voice of the Customer. This platform is built on extensive customer experience research and enables businesses to gather and share valuable insights across their teams. The insights generated can enhance sales performance, boost customer loyalty, and improve compliance, ultimately leading to more informed business decisions and reduced operating costs.

Lindy Biosciences is a development-stage protein therapeutic formulations company. Our core technology produces spherical, dense, stable particles of a therapeutic protein. These protein particles are ideal for long-term storage, or for non-standard formulations such as suspension formulations (for high-concentration delivery of antibodies), encapsulation (for sustained/controlled release), or dry powder pulmonary delivery.​

Peekd mission is to help clients excel by providing perfect market insights.